Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

ANALYSIS: Measuring R&D success and myth

This article was originally published in Scrip

Executive Summary

Who has been the best Big Pharma research and development (R&D) chief in the pharmaceutical industry recently? Those interested in the industry likely have found themselves asking this question. Often, it is argued that it is difficult to make an apples-to-apples judgment due to long development timelines, or different market climates.



Related Companies